<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="420015" id="root" date="1997-03-05" xml:lang="en">
<title>USA: Osmotics pegs wrinkle market at $800 million.</title>
<headline>Osmotics pegs wrinkle market at $800 million.</headline>
<dateline>CHICAGO 1997-03-05</dateline>
<text>
<p>Osmotics Corp sees a potential $800 million market niche developing in the cosmetics industry for skin patches designed to minimize wrinkles, president Steven Porter told a meeting of investment analysts on Wednesday.</p>
<p>Denver-based Osmotics, which expects to go public within the next six weeks via a 1,125,000 share offering, reported a strong retail demand for the company's line of such transdermal cosmetic skin care products.  </p>
<p>The company's Antioxidant Skin Care Derms are sold as patches which, applied to the skin, deliver a dose of Vitamin C that is designed to reduce the appearance of fine facial lines. The patches account for about 80 percent of Osmotics' revenues, which totaled $1.3 million in 1996.</p>
<p>Porter said his company, which is seeking U.S. patent approval on its patch as a method of delivering antioxidants, is in talks with two large cosmetic companies on licensing possibilities.</p>
<p>Though its products are used primarily for crow's feet, upper lip lines and brow furrows, Osmotics eventually plans to introduce a variety of new patch shapes.</p>
<p>Osmotics has applied for listing on the Nasdaq SmallCap Market under the &quot;OSMO&quot; symbol. National Securities Corp is the underwriter for the pulbic offering.</p>
<p>((Chicago newsdesk 312 408-8787))</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25800">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C14">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="C17">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="C171">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-03-05"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-03-05"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="CHICAGO"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
